4
Changes in Ownership
PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001641172-25-005519
Options or other derivatives
- CEO acquired 0 shares (option exercise)
- CEO acquired 9,438 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Pershing Edward · CEO
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-04-19 | Exercise or conversion : show line 1 in the form 8% Unsecured Convertible Promissory Note | −0 | D | |
| 2025-04-19 | Exercise or conversion : show line 2 in the form Series D-1 Convertible Preferred Stock | +9,438 | 2,072,976 | D |
Loading xslF345X05/ownership.xml…